Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Newborn Screening for SMA – Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
Astrid Blaschek, Heike Kölbel, Oliver Schwartz, et al.
Journal of Neuromuscular Diseases (2022) Vol. 9, Iss. 5, pp. 597-605
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Spinal Muscular Atrophy Treatment in Patients Identified by Newborn Screening—A Systematic Review
Karolina Aragon‐Gawinska, Charlotte Mouraux, Tamara Dangouloff, et al.
Genes (2023) Vol. 14, Iss. 7, pp. 1377-1377
Open Access | Times Cited: 47
Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy
Oliver Schwartz, Katharina Vill, Michelle Pfaffenlehner, et al.
JAMA Pediatrics (2024) Vol. 178, Iss. 6, pp. 540-540
Closed Access | Times Cited: 23
Challenges and opportunities in spinal muscular atrophy therapeutics
Crystal Jing Jing Yeo, Eduardo F. Tizzano, Basil T. Darras
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 205-218
Closed Access | Times Cited: 21
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England
Diana Weidlich, Laurent Servais, Imran Kausar, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 4, pp. 1205-1220
Open Access | Times Cited: 24
Experience of a 2-year spinal muscular atrophy NBS pilot study in Italy: towards specific guidelines and standard operating procedures for the molecular diagnosis
Emanuela Abiusi, Alessandro Vaisfeld, Stefania Fiori, et al.
Journal of Medical Genetics (2022) Vol. 60, Iss. 7, pp. 697-705
Closed Access | Times Cited: 29
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2
Katharina Vill, Moritz Tacke, Anna König, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2787-2797
Open Access | Times Cited: 8
Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians
Sithara Ramdas, Maryam Oskoui, Laurent Servais
Drugs (2024) Vol. 84, Iss. 7, pp. 747-762
Closed Access | Times Cited: 5
Cost-Effectiveness Analysis of Newborn Screening for Spinal Muscular Atrophy in Italy
Gianni Ghetti, Francesco Saverio Mennini, Andrea Marcellusi, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 9, pp. 687-701
Open Access | Times Cited: 5
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?
Martina Ricci, Gianpaolo Cicala, Anna Capasso, et al.
Annals of Neurology (2023) Vol. 94, Iss. 6, pp. 1126-1135
Open Access | Times Cited: 13
Deciphering spinal muscular atrophy: the need for more research
Michelle A. Farrar, Didu Sanduni Kariyawasam
The Lancet Neurology (2024) Vol. 23, Iss. 2, pp. 134-136
Closed Access | Times Cited: 4
Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy
Katy Cooper, Gamze Nalbant, Anthea Sutton, et al.
International Journal of Neonatal Screening (2024) Vol. 10, Iss. 3, pp. 56-56
Open Access | Times Cited: 4
Views of the Public and Healthcare Professionals on Newborn Screening for Spinal Muscular Atrophy and the Potential for Detecting Adult-Onset Types in Patients-in-Waiting in Hong Kong
Chloe Miu Mak, J. K. Lee, Jimmy Chi Lap Wong, et al.
Cureus (2025)
Open Access
[Research progress on phenotypic modifier genes in spinal muscular atrophy].
Wei Pan, Cao Yanyan
PubMed (2025) Vol. 27, Iss. 2, pp. 229-235
Closed Access
Spectrum of Phenotypes in SMA Patients With 4 SMN2 Copies in the French Population
Lorène Gerin, Juliette Ropars, Rocío Garcia-Uzquiano, et al.
Neurology Genetics (2025) Vol. 11, Iss. 2
Open Access
Family doctor and paediatrician care for a patient with spinal muscular atrophy
Paweł Małecki, Cezary Witczak, Radosław Rutkowski, et al.
Pediatria i Medycyna Rodzinna (2025) Vol. 21, Iss. 1, pp. 29-34
Open Access
The Importance of Early Treatment of Inherited Neuromuscular Conditions
Laurane Mackels, Laurent Servais
Journal of Neuromuscular Diseases (2024) Vol. 11, Iss. 2, pp. 253-274
Open Access | Times Cited: 3
Clinical Perspectives: Treating Spinal Muscular Atrophy
Molly McPheron, Marcia V. Felker
Molecular Therapy (2024) Vol. 32, Iss. 8, pp. 2489-2504
Closed Access | Times Cited: 3
Spinal Muscular Atrophy
Maryam Oskoui, Laurent Servais
CONTINUUM Lifelong Learning in Neurology (2023) Vol. 29, Iss. 5, pp. 1564-1584
Closed Access | Times Cited: 8
The modern face of newborn screening
Yin‐Hsiu Chien, Wuh‐Liang Hwu
Pediatrics & Neonatology (2022) Vol. 64, pp. S22-S29
Closed Access | Times Cited: 11
Nusinersen demonstrates effectiveness in treating spinal muscular atrophy: findings from a three-year nationwide study in Korea
Jaeso Cho, Jiwon Lee, Ji-Hye Kim, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Newborn screening for spinal muscular atrophy - what have we learned?
Alzira Alves de Siqueira Carvalho, Cyril Tychon, Laurent Servais
Expert Review of Neurotherapeutics (2023) Vol. 23, Iss. 11, pp. 1005-1012
Closed Access | Times Cited: 5
Parental Burden and Quality of Life in 5q-SMA Diagnosed by Newborn Screening
Heike Kölbel, Laura Modler, Astrid Blaschek, et al.
Children (2022) Vol. 9, Iss. 12, pp. 1829-1829
Open Access | Times Cited: 8
Outcomes for patients in the RESTORE registry with spinal muscular atrophy and four or more SMN2 gene copies treated with onasemnogene abeparvovec
Eduardo F. Tizzano, Susana Quijano-Roy, Laurent Servais, et al.
European Journal of Paediatric Neurology (2024) Vol. 53, pp. 18-24
Open Access | Times Cited: 1
Proteomics profiling and machine learning in nusinersen-treated patients with spinal muscular atrophy
Chiara Panicucci, Eray Şahin, Martina Bartolucci, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Identification of Biochemical Determinants for Diagnosis and Prediction of Severity in 5q Spinal Muscular Atrophy Using 1H-Nuclear Magnetic Resonance Metabolic Profiling in Patient-Derived Biofluids
Afshin Saffari, Moritz Niesert, Claire Cannet, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12123-12123
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top